Market Analysis and Insights: Global Low Molecular Weight Heparin Sodium Market

Due to the COVID-19 pandemic, the global Low Molecular Weight Heparin Sodium market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Low Molecular Weight Heparin Sodium global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.

The United States Low Molecular Weight Heparin Sodium market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the United States is % in 2021, while Chinese percentage is %, and it is predicted that China’s share will reach % in 2028, trailing a CAGR of % through the analysis period.

The global key manufacturers of Low Molecular Weight Heparin Sodium include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutica, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

In United States, in terms of revenue, in 2021, the top three players hold a share about %, while in China, top three players hold a share nearly %.

Global Low Molecular Weight Heparin Sodium Scope and Market Size

The global Low Molecular Weight Heparin Sodium market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Low Molecular Weight Heparin Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.


Segment by Type


Enoxaparin

Dalteparin

Tinzaparin

Fraxiparine


Segment by Application


Medical

Research

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Aspen

Sanofi-aventis

Pfizer

Opocrin

CSBIO

Dongying Tiandong Pharmaceutica

Changzhou Qianhong Bio-pharma

Techdow

Yantai Dongcheng Pharmaceutical Group